Structured Summary
Abstract
Cytolytic lymphocytes with the unique capacity of killing natural killer (NK)-resistant fresh tumor cells. They are INTERLEUKIN-2-activated NK cells that have no MAJOR HISTOCOMPATIBILITY COMPLEX restriction or need for antigen stimulation. LAK cells are used for ADOPTIVE IMMUNOTHERAPY in cancer patients.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
MeSH Record
See Also
MeSH Record
Synonyms
11 entry terms
- Killer Cells, Lymphokine-Activated
- LAK Cells
- Cell, LAK
- Cell, Lymphokine-Activated Killer
- Cells, LAK
- Cells, Lymphokine-Activated Killer
- Killer Cell, Lymphokine-Activated
- Killer Cells, Lymphokine Activated
- LAK Cell
- Lymphokine Activated Killer Cells
- Lymphokine-Activated Killer Cell
MeSH Record
Aspects Covered
15 allowable subheadings
Indexed with the subheadings chemistry, classification, cytology, drug effects, enzymology, immunology, metabolism, microbiology, parasitology, pathology, physiology, radiation effects, transplantation, ultrastructure, virology.
MeSH Record
Indexing Annotation
if subpopulations are discussed, coordinate IM with LYMPHOCYTE SUBSETS (IM)
MeSH Record
History Note
90
MeSH Record
Previous Indexing
- Killer Cells, Natural (1982-1989)
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Lymphokine-Activated Killer Cells. Medical Subject Headings (MeSH). 2026. Unique ID D015979. http://id.nlm.nih.gov/mesh/2026/D015979
- Lymphokine-Activated Killer Cells. In: Wikipedia. https://en.wikipedia.org/wiki/Lymphokine-activated_killer_cell
- Lymphokine-Activated Killer Cells. In: Wikidata. https://www.wikidata.org/wiki/Q4259786